Tysabri
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Abstract The objective of the study was to obtain information on the toxicity of biosimilar natalizumab (PB006) in comparison to…
Background There is a significant UK variation in the DMT sequencing strategies for high PML risk patients on Tysabri. In Greater…
Introduction We aimed to report a single patient seen at a tertiary neurology centre with a rarely described phenomenon of…
Entyvio (vedolizumab), Takeda’s drug for inflammatory bowel disease (IBD), is in line to become the first integrin inhibitor to…
1135 has shown side effects that include a slowed heart rate, macular edema and breathing and liver problems. Although these may…
Therapeutic monoclonal antibodies are potent new tools for a molecular targeted approach to modify the course of multiple…
La Agencia Espanola de Medicamentos y Productos Sanitarios (AEMPS) ha recibido nueva
informacion de seguridad concerniente al…
Although the financial implications of Elan's and Biogen Idec's shock withdrawal from the market of the highly promising multiple…